Quick Answer
RXO, Inc. reported Cash and Equivalents of $17.00 million for fiscal year 2025.
RXO, Inc. Cash and Equivalents — Annual History
| Fiscal Year | Cash and Equivalents | YoY Change |
|---|---|---|
| 2025 | $17.00M | -51.4% |
| 2024 | $35.00M | +600.0% |
| 2023 | $5.00M | -94.9% |
| 2022 | $98.00M | +237.9% |
| 2021 | $29.00M | — |
Quarterly Cash and Equivalents
| Quarter Ending | Cash and Equivalents | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $25.00M | -54.5% | +38.9% |
| June 30, 2025 | $18.00M | +157.1% | +12.5% |
| March 31, 2025 | $16.00M | +128.6% | -54.3% |
| December 31, 2024 | $35.00M | +600.0% | -36.4% |
| September 30, 2024 | $55.00M | -47.1% | +685.7% |
| June 30, 2024 | $7.00M | -94.4% | +0.0% |
| March 31, 2024 | $7.00M | -94.2% | +40.0% |
| December 31, 2023 | $5.00M | -94.9% | -95.2% |
- RXO, Inc. showed a decrease of -51.4% in Cash and Equivalents compared to the prior fiscal year.
- Over the 2021–2025 period, RXO, Inc.’s cash and equivalents has declined by 41.4% (from $29.00 million to $17.00 million).
- The most recent figure is from RXO, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 9, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: